Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 53, Issue 17, Pages 6477-6489Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm1006484
Keywords
-
Categories
Funding
- The Medical Research Foundation of Oregon [0530]
- National Institutes of Health [AI067837, AI072923]
- Murdock Charitable Trust
- Direct For Mathematical & Physical Scien
- Division Of Chemistry [741993] Funding Source: National Science Foundation
Ask authors/readers for more resources
We have previously shown that a reversed chloroquine (RCQ) molecule, composed of a chloroquine-like moiety and a resistance reversal-like moiety, can overcome chloroquine resistance in P. falciparum (Burgess, S. J.; Selzer; A.; Kelly, J. X.; Smilkstein, M. J.; Riscoe, M. K.; Peyton, D. H. J. Med. Chem. 2006, 49, 5623. Andrews, S.; Burgess, S. J.; Skaalrud, D.; Kelly, J. X.; Peyton, D. H. J. Med. Chem. 2010, 53, 916). Here, we present an investigation into the structure-activity relationship of the RCQ structures, resulting in an orally active molecule with good in vitro and in vivo antimalarial activity. We also present evidence of the mode of action, indicating that the RCQ molecules inhibit hemozoin formation in the parasite's digestive vacuole in a manner similar to that of chloroquine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available